Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -48.57% is 75% below its 5-year average of -27.69%, near the low end of its 5-year range (-48.57%–-9.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.93% below its 12-month average of -37.38%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -48.57%.
RETURN ON INVESTED CAPITAL (ROIC)
-48.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.93%
CURRENT VS 3Y AVG
-49.38%
CURRENT VS 5Y AVG
-75.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-36.27%
vs the sector median at left
Edgewise Therapeutics, Inc.
Market Cap
$4.31B
Return on Invested Capital (ROIC)
-48.57%
TTM Avg
-37.38%
3Y Avg
-32.52%
5Y Avg
-27.69%
Market Cap
$4.31B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-24.96%
3Y Avg
-29.08%
5Y Avg
-26.21%
Market Cap
$4.37B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$4.48B
Return on Invested Capital (ROIC)
N/A
TTM Avg
37.59%
3Y Avg
8.11%
5Y Avg
6.10%
Market Cap
$4.12B
Return on Invested Capital (ROIC)
10.24%
TTM Avg
7.56%
3Y Avg
2.02%
5Y Avg
-0.82%
Market Cap
$4.11B
Return on Invested Capital (ROIC)
-33.87%
TTM Avg
-48.11%
3Y Avg
-42.73%
5Y Avg
-35.85%
Market Cap
$4.02B
Return on Invested Capital (ROIC)
-17.95%
TTM Avg
-20.66%
3Y Avg
-12.14%
5Y Avg
-3.93%
Market Cap
$4.60B
Return on Invested Capital (ROIC)
6.39%
TTM Avg
-7.12%
3Y Avg
-17.71%
5Y Avg
-17.71%
Market Cap
$3.99B
Return on Invested Capital (ROIC)
3.11%
TTM Avg
1.40%
3Y Avg
0.58%
5Y Avg
2.33%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.31B | -48.57% | -37.38% | -32.52% | -27.69% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | -6.67% | -24.96% | -29.08% | -26.21% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | -23.69% | -46.07% | -46.68% | -46.68% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | N/A | 37.59% | 8.11% | 6.10% |
| LivaNova PLC (LIVN)vs › | $4.12B | 10.24% | 7.56% | 2.02% | -0.82% |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.11B | -33.87% | -48.11% | -42.73% | -35.85% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | -17.95% | -20.66% | -12.14% | -3.93% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 6.39% | -7.12% | -17.71% | -17.71% |
| ICU Medical, Inc. (ICUI)vs › | $3.99B | 3.11% | 1.40% | 0.58% | 2.33% |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 9.68% | 9.25% | 8.40% | 7.66% |
ROIC
-48.6%
ROE
-44.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -48.57% |
| 2026-03-31 | -40.24% |
| 2025-12-31 | -36.44% |
| 2025-09-30 | -32.21% |
| 2025-06-30 | -29.46% |
| 2025-03-31 | -39.24% |
| 2024-12-31 | -34.31% |
| 2024-09-30 | -29.89% |
| 2024-06-30 | -26.47% |
| 2024-03-31 | -22.89% |
| 2023-12-31 | -35.38% |
| 2023-09-30 | -34.77% |
| 2023-06-30 | -28.90% |
| 2023-03-31 | -24.73% |
| 2022-12-31 | -20.44% |
| 2022-09-30 | -17.15% |
| 2022-06-30 | -23.05% |
| 2022-03-31 | -19.48% |
| 2021-12-31 | -15.73% |
| 2021-09-30 | -12.86% |
| 2021-06-30 | -9.20% |
| 2021-03-31 | -6.79% |
| 2020-12-31 | -13.56% |
